Cargando…

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance

Normal cells produce adenosine 5′-triphosphate (ATP) mainly through mitochondrial oxidative phosphorylation (OXPHOS) when oxygen is available. Most cancer cells, on the other hand, are known to produce energy predominantly through accelerated glycolysis, followed by lactic acid fermentation even und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Ayako, Kobayashi, Minoru, Koyasu, Sho, Chow, Christalle C. T., Harada, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359724/ https://www.ncbi.nlm.nih.gov/pubmed/30634433 http://dx.doi.org/10.3390/ijms20020238

Ejemplares similares

UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
por: Nakashima, Ryota, et al.
Publicado: (2017)

An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
por: Shirai, Yukari, et al.
Publicado: (2021)

HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs
por: Zhao, Tao, et al.
Publicado: (2014)

Regulatory mechanisms of hypoxia‐inducible factor 1 activity: Two decades of knowledge
por: Koyasu, Sho, et al.
Publicado: (2018)

The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells
por: Battello, Nadia, et al.
Publicado: (2016)

Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
por: Jin, Jinmei, et al.
Publicado: (2019)

Imatinib-resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprogramming
por: Zhao, Fangping, et al.
Publicado: (2010)

Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
por: Huang, Pengzhu, et al.
Publicado: (2023)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023)

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
por: Nelson, Jessica K., et al.
Publicado: (2022)

Metabolic Reprogramming and Inflammatory Response Induced by D-Lactate in Bovine Fibroblast-Like Synoviocytes Depends on HIF-1 Activity
por: Quiroga, John, et al.
Publicado: (2021)

Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway(✰)
por: Lian, Guan, et al.
Publicado: (2019)

Salidroside orchestrates metabolic reprogramming by regulating the Hif-1α signalling pathway in acute mountain sickness
por: Yan, Xiaoning, et al.
Publicado: (2021)

Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)

Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020)

Reprogramming of glucose metabolism in virus infected cells
por: Goyal, Priya, et al.
Publicado: (2023)

HIF-1α-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected Hamsters
por: Jana, Sirsendu, et al.
Publicado: (2022)

CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by Modulating HIF-1α Signaling Pathway
por: Zhang, Zheng, et al.
Publicado: (2022)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation
por: Chen, Yongchang, et al.
Publicado: (2022)

HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog
por: Katagiri, Tomohiro, et al.
Publicado: (2018)

STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection
por: Gomes, Marco Tulio R., et al.
Publicado: (2021)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells
por: Lee, Hyun Jik, et al.
Publicado: (2019)

MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
por: Zhang, Ze, et al.
Publicado: (2019)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
por: Nguyen, Trang T. T., et al.
Publicado: (2022)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

HIF-1α is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium
por: Wu, David, et al.
Publicado: (2017)

HIF1α Regulates Early Metabolic Changes due to Activation of Innate Immunity in Nuclear Reprogramming
por: Liu, Chun, et al.
Publicado: (2020)

IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
por: Shigeta, Keisuke, et al.
Publicado: (2023)

Hypoxia-induced reprogramming of glucose-dependent metabolic pathways maintains the stemness of human bone marrow-derived endothelial progenitor cells
por: Lin, Dongni, et al.
Publicado: (2023)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
por: Badoiu, Silviu Constantin, et al.
Publicado: (2023)

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
por: Van Wyngene, Lise, et al.
Publicado: (2018)

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
por: Huang, Yiwei, et al.
Publicado: (2021)

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
por: Zhou, Xinke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d87kpvbfav8gncc7a1jb5bmefl